Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho
Go back to Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.14 | 52 Week High | $108.63 | |||
| Open | $138.14 | 52 Week Low | $71.39 | |||
| Day High | $138.14 | P/E | 76.32 | |||
| Day Low | $138.14 | EPS | $1.81 | |||
| Volume | 582 | |||||
| (NYSE: RCUS) | Delayed: 28.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.86 | 52 Week High | $ | |||
| Open | $28.86 | 52 Week Low | $ | |||
| Day High | $28.86 | P/E | N/A | |||
| Day Low | $28.86 | EPS | $ | |||
| Volume | 4,704 | |||||

